Here, we identify chromatin-modifying protein/charged multivesicular body protein (CHMP2A) as a target for increasing GSC and HNSCC cell sensitivity to NK cell-mediated killing. This evidence concerns the gene CHMP2A and head and neck squamous cell carcinoma.